There is another hopeful milestone Sunday after the FDA issued an emergency-use authorization for Regeneron's antibody cocktail to treat the coronavirus.
Emily Turner reports.
(11-22-20)
Mayo Clinic experimental treatment for COVID-19 patients
KIMT
The treatment is a one hour infusion that's done outpatient and you have to be monitored for an hour afterwards.
